Sanara MedTech
SMTI
28 hedge funds and large institutions have $9.94M invested in Sanara MedTech in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.
82% more capital invested
Capital invested by funds: $5.45M → $9.94M (+$4.49M)
33% more funds holding
Funds holding: 21 → 28 (+7)
0.76% more ownership
Funds ownership: 3.27% → 4.03% (+0.76%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$1.54M |
| 2 |
State Street
Boston,
Massachusetts
|
+$224K |
| 3 |
QC
Quadrature Capital
London,
United Kingdom
|
+$193K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$109K |
| 5 |
Morgan Stanley
New York
|
+$57.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Prelude Capital Management
New York
|
-$124K |
| 2 |
Lazard Asset Management
New York
|
-$28.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$22.3K |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$17.7K |
| 5 |
BlackRock
New York
|
-$7.67K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $4K | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $1K | +$28 | +1 | +5% |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$364 | +13 | +1,300% |
|
SMTI Hedge Fund Activity: Q3 2022 in Review
28 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2022, worth a combined $9.94M — up 82% from $5.45M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SMTI positions and 0 closed out — a net gain of 7 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $1.54M. The largest seller was Prelude Capital Management, cutting an estimated $124K.
- 28 institutional investors held Sanara MedTech (SMTI) as of Q3 2022, up from 21 in Q2 2022.
- Funds reported $9.94M of Sanara MedTech stock for Q3 2022, up 82% quarter-over-quarter.
- 7 funds opened new Sanara MedTech positions in Q3 2022 and 0 closed out, a net change of +7 holders.
- The largest Sanara MedTech buyer in Q3 2022 was EAM Investors, an estimated $1.54M added.
- The largest Sanara MedTech seller in Q3 2022 was Prelude Capital Management, an estimated $124K sold.
Based on aggregated 13F filings for Q3 2022.